Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.95
+0.02 (+0.05%)
Streaming Delayed Price
Updated: 1:40 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,826,342
Open
28.48
Bid (Size)
28.94 (34)
Ask (Size)
28.95 (7)
Prev. Close
28.93
Today's Range
28.31 - 28.98
52wk Range
25.20 - 34.11
Shares Outstanding
5,606,688,356
Dividend Yield
5.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
Today 10:29 EDT
Pfizer has withdrawn Oxbryta from global markets and halted all clinical trials, citing safety concerns following clinical data that raised issues about fatal complications in sickle cell disease...
Via
Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Today 10:20 EDT
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.
Via
Investor's Business Daily
Performance
YTD
-2.64%
-2.64%
1 Month
+0.09%
+0.09%
3 Month
+5.56%
+5.56%
6 Month
+4.19%
+4.19%
1 Year
-10.66%
-10.66%
More News
Read More
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
Today 7:45 EDT
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Today 4:07 EDT
Via
The Motley Fool
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
September 25, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer Unusual Options Activity
September 24, 2024
Via
Benzinga
Current Report: Pfizer (PFE)
September 19, 2024
Via
Talk Markets
Pfizer Unusual Options Activity
September 17, 2024
Via
Benzinga
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
September 25, 2024
Via
The Motley Fool
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
September 24, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
September 23, 2024
Via
Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
Via
The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Via
The Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 20, 2024
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
Pfizer Inc.
Via
Business Wire
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
Via
FinancialNewsMedia
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
September 18, 2024
Via
Benzinga
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
September 18, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
Via
The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
September 17, 2024
From
Pfizer Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.